TY - BOOK AU - Bansi, L.K. AU - Benzie, A.A. AU - Phillips, A.N. AU - Portsmouth, S. AU - Hill, T. AU - Leen, C. AU - Schwenk, A. AU - Johnson, M. AU - Anderson, J. AU - Gilson, R. AU - Easterbrook, P. AU - Gazzard, B. AU - Fisher, M. AU - Orkin, C. AU - Porter, K. AU - Pillay, D. AU - Taylor, G.P. AU - Walsh, J.C. AU - Sabin, C.A. ED - UK Collaborative HIV Cohort (UK CHIC) Study. TI - Are previous treatment interruptions associated with higher viral rebound rates in patients with viral suppression? SN - 02699370 PY - 2008/// N1 - NMUH Staff Publications; 22 N2 - <div style="line-height: 17.999801635742188px;"><h4 style="margin: 0px 0.25em 0px 0px; text-transform: uppercase; float: left;"><span style="font-size: 10pt;">OBJECTIVE:</span></h4><p style="margin: 0px 0px 0.5em;"><span style="font-size: 8pt;"><span style="font-size: 10pt;">We investigated whether&nbsp;<span class="highlight">previous</span>&nbsp;<span class="highlight">treatment</span>&nbsp;<span class="highlight">interruptions</span>&nbsp;are&nbsp;<span class="highlight">associated</span>&nbsp;with a raised risk of&nbsp;<span class="highlight">viral</span>&nbsp;<span class="highlight">rebound</span>&nbsp;in individuals who have attained virological suppression.</span></span></p><h4 style="margin: 0px 0.25em 0px 0px; text-transform: uppercase; float: left;"><span style="font-size: 10pt;">METHODS:</span></h4><p style="margin: 0px 0px 0.5em;"><span style="font-size: 10pt;">All&nbsp;<span class="highlight">patients</span>&nbsp;achieving an undetectable&nbsp;<span class="highlight">viral</span>&nbsp;load while on&nbsp;<span class="highlight">therapy</span>&nbsp;were followed until&nbsp;<span class="highlight">viral</span>&nbsp;<span class="highlight">rebound</span>&nbsp;or the time of the last&nbsp;<span class="highlight">viral</span>&nbsp;load. Poisson regression was used to describe the independent impact of&nbsp;<span class="highlight">treatment</span>&nbsp;<span class="highlight">interruptions</span>&nbsp;on&nbsp;<span class="highlight">rebound</span>&nbsp;<span class="highlight">rates</span>.</span></p><h4 style="margin: 0px 0.25em 0px 0px; text-transform: uppercase; float: left;"><span style="font-size: 10pt;">RESULTS:</span></h4><p style="margin: 0px 0px 0.5em;"><span style="font-size: 10pt;">A total of 12,977&nbsp;<span class="highlight">patients</span>&nbsp;from the United Kingdom Collaborative HIV Cohort (UK CHIC) Study achieved a&nbsp;<span class="highlight">viral</span>&nbsp;load of less than 50 copies/ml. These&nbsp;<span class="highlight">patients</span>&nbsp;contributed a total of 37,314 person-years of follow-up. The overall&nbsp;<span class="highlight">rebound</span>&nbsp;rate was 8.07 (7.78, 8.36) per 100 person-years. In adjusted analyses,&nbsp;<span class="highlight">rates</span>&nbsp;of&nbsp;<span class="highlight">viral</span>&nbsp;<span class="highlight">rebound</span>&nbsp;were up to 64%&nbsp;<span class="highlight">higher</span>&nbsp;(rate ratio 1.64; 1.43, 1.88) in those who had previously interrupted&nbsp;<span class="highlight">therapy</span>&nbsp;compared with those who had not.&nbsp;<span class="highlight">Patients</span>&nbsp;who had interrupted at detectable&nbsp;<span class="highlight">viral</span>&nbsp;loads had up to a 74% (1.74; 1.42, 2.14)&nbsp;<span class="highlight">higher</span>&nbsp;chance of rebounding compared with those who had not interrupted with a detectable&nbsp;<span class="highlight">viral</span>&nbsp;load. We found no evidence to suggest interrupting&nbsp;<span class="highlight">treatment</span>&nbsp;at an undetectable&nbsp;<span class="highlight">viral</span>&nbsp;load was&nbsp;<span class="highlight">associated</span>&nbsp;with&nbsp;<span class="highlight">viral</span>&nbsp;<span class="highlight">rebound</span>.</span></p><h4 style="margin: 0px 0.25em 0px 0px; text-transform: uppercase; float: left;"><span style="font-size: 10pt;">CONCLUSION:</span></h4><p style="margin: 0px 0px 0.5em;"><span style="font-size: 8pt;"><span style="font-size: 10pt;">Among&nbsp;<span class="highlight">patients</span>&nbsp;with an undetectable&nbsp;<span class="highlight">viral</span>&nbsp;load, having previously interrupted&nbsp;<span class="highlight">therapy</span>&nbsp;while the&nbsp;<span class="highlight">viral</span>&nbsp;load was detectable is&nbsp;<span class="highlight">associated</span>&nbsp;with a raised risk of&nbsp;<span class="highlight">rebound</span>.</span></span></p></div> UR - http://www.ncbi.nlm.nih.gov/pubmed/?term=Are+previous+treatment+interruptions+associated+with+higher+viral+rebound+rates+in+patients+with+viral+suppression%3F ER -